Q2 2026 Holdings
Filed 2026-08-14 | 164 holdings | $4.8B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Amgen Inc(AMGN) | COM | 031162100 | $308.4M | 851,550 | 6.5% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $287.4M | 578,634 | 6.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $279.3M | 301,000 | 5.9% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $272.7M | 2,158,772 | 5.7% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $196.3M | 1,048,014 | 4.1% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $157.7M | 1,657,190 | 3.3% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $148.6M | 1,393,418 | 3.1% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $134.7M | 2,449,547 | 2.8% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $130.1M | 1,053,268 | 2.7% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $123.7M | 6,731,909 | 2.6% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $115.7M | 6,185,970 | 2.4% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $114.6M | 1,971,935 | 2.4% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $102.1M | 188,515 | 2.1% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $101.3M | 254,809 | 2.1% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $98.1M | 157,291 | 2.1% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $98.0M | 2,620,000 | 2.1% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $88.6M | 1,189,506 | 1.9% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $88.5M | 2,788,245 | 1.9% |
| Abbott Laboratories(ABT) | COM | 002824100 | $85.9M | 947,115 | 1.8% |
| Stryker Corporation(SYK) | COM | 863667101 | $84.5M | 268,461 | 1.8% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $77.8M | 994,233 | 1.6% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $77.1M | 972,258 | 1.6% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $75.6M | 1,490,000 | 1.6% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $73.4M | 1,710,808 | 1.5% |
| Jade Biosciences Inc(JBIO) | COM NEW | 008064206 | $67.9M | 3,057,996 | 1.4% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $66.9M | 739,234 | 1.4% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $66.2M | 1,982,775 | 1.4% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $62.0M | 149,127 | 1.3% |
| Dexcom Inc(DXCM) | COM | 252131107 | $55.4M | 822,489 | 1.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $44.7M | 1,200,000 | 0.9% |
| Avalyn Pharmaceuticals Inc(AVLN) | COM SHS | 05348Y105 | $44.4M | 1,350,000 | 0.9% |
| Damora Therapeutics Inc(GLTO) | COM NEW | 36322Q206 | $42.1M | 1,618,846 | 0.9% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $41.0M | 560,000 | 0.9% |
| Thermo Fisher Scientific Inc(TMO) | COM | 883556102 | $40.0M | 79,816 | 0.8% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $37.9M | 887,650 | 0.8% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $35.8M | 29,882 | 0.8% |
| CG Oncology Inc(CGON) | COM | 156944100 | $35.1M | 493,596 | 0.7% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $32.5M | 61,780 | 0.7% |
| Resmed Inc(RMD) | COM | 761152107 | $28.9M | 148,195 | 0.6% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $28.8M | 77,530 | 0.6% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $28.8M | 1,190,000 | 0.6% |
| Danaher Corp del(DHR) | COM | 235851102 | $27.4M | 143,844 | 0.6% |
| Johnson & Johnson(JNJ) | COM | 478160104 | $26.2M | 103,280 | 0.6% |
| Seaport Therapeutics Inc(SPTX) | COMMON STOCK | 81221K108 | $23.9M | 1,100,000 | 0.5% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $23.7M | 155,000 | 0.5% |
| Align Technology Inc(ALGN) | COM | 016255101 | $23.6M | 139,680 | 0.5% |
| Annexon Inc(ANNX) | COM | 03589W102 | $23.4M | 4,100,016 | 0.5% |
| Humana Inc(HUM) | COM | 444859102 | $23.2M | 58,398 | 0.5% |
| Elevance Health Inc Formerly(ELV) | COM | 036752103 | $21.8M | 56,449 | 0.5% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $21.7M | 694,182 | 0.5% |